Ulcerative colitis is diagnosed through a combination of stool tests, blood work, colonoscopy with tissue biopsies, and careful ruling out of other conditions. No single test confirms it on its own. Instead, doctors piece together evidence from multiple sources to identify the characteristic pattern of continuous inflammation in the colon’s inner lining.
Stool Tests: The Usual First Step
Before scheduling a colonoscopy, most doctors will order a stool test to check for signs of intestinal inflammation. The most widely used is fecal calprotectin, a protein released by white blood cells when they’re active in the gut. A normal result (below 50 micrograms per gram) makes inflammatory bowel disease much less likely, while a reading above 250 suggests a need for colonoscopy to investigate further. At a cutoff of 50, calprotectin catches about 89% of IBD cases and correctly rules it out about 81% of the time. Raising the threshold to 100 pushes accuracy even higher, with sensitivity reaching 98% and specificity 91%.
Calprotectin outperforms standard blood markers like C-reactive protein (CRP) and white blood cell counts at reflecting what’s actually happening inside the colon. It correlates more closely with both the visible appearance of the lining during colonoscopy and the microscopic findings on biopsy. A similar stool marker called fecal lactoferrin is sometimes used instead, with comparable though slightly lower sensitivity (67% to 91%).
Stool samples are also tested for bacterial infections like C. difficile, Salmonella, and E. coli, since these can mimic UC symptoms almost exactly. Ruling out infection is essential before moving forward.
Blood Tests and Antibody Panels
Routine blood work helps gauge the overall impact of the disease. Doctors look for anemia (common when chronic bleeding is involved), elevated inflammatory markers like CRP and erythrocyte sedimentation rate (ESR), and low albumin levels that can signal poor nutrient absorption or ongoing inflammation.
Specialized antibody tests can help distinguish UC from Crohn’s disease when the picture is unclear. A pattern called pANCA-positive/ASCA-negative is associated with ulcerative colitis, while the reverse pattern (pANCA-negative/ASCA-positive) points toward Crohn’s. However, these antibody patterns have limited sensitivity. The pANCA-positive/ASCA-negative combination identifies only about 36% of UC patients, though when it is positive, it’s highly specific at 98%, meaning false positives are rare. These tests are helpful when they’re positive but don’t rule anything out when they’re negative.
Colonoscopy: The Central Diagnostic Tool
Colonoscopy is the definitive step. A gastroenterologist uses a flexible camera to examine the entire colon and rectum, looking for the hallmark pattern of UC: continuous inflammation that starts at the rectum and extends upward without gaps. This stands in direct contrast to Crohn’s disease, which tends to skip areas, leaving patches of healthy tissue between inflamed segments.
During the procedure, doctors assess the severity of what they see using a grading system called the Mayo Endoscopic Subscore, scored from 0 to 3. A score of 0 means the lining looks normal. A score of 1 indicates mild disease with some redness and decreased visibility of the blood vessel pattern. Scores of 2 and 3 represent moderate and severe disease, with visible ulcers, spontaneous bleeding, or both.
Crucially, the doctor takes multiple small tissue samples (biopsies) from different areas of the colon, including areas that look normal. These samples are sent to a pathologist and are often what clinches the diagnosis.
Preparing for a Colonoscopy
The bowel prep is the part most people dread, and it starts about two days beforehand. You’ll eat a small, light dinner two nights before the procedure, then switch to clear liquids only for the entire day before. That means broth, clear juice without pulp, popsicles, sports drinks, and black coffee or tea. No solid food. The afternoon before, you’ll take a laxative, and the morning of the procedure you’ll drink a second round of prep solution, typically finishing it about five hours before you leave for the appointment. Nothing at all goes in your mouth during the final four hours, not even water, or the procedure may be delayed or canceled.
What Biopsies Reveal Under the Microscope
Biopsy results are where the distinction between UC and other conditions becomes clearest. Pathologists look for a specific combination of active inflammation and signs of chronic damage. Active inflammation shows up as white blood cells (neutrophils) invading the glands that line the colon. When neutrophils collect inside these glands, they form what are called crypt abscesses, a characteristic finding in UC.
Chronic damage is equally important. The glands in a healthy colon are evenly spaced and run straight down to the muscle layer beneath. In UC, these glands become shortened, branched, and irregularly shaped, a feature called crypt architectural distortion. Another hallmark is a buildup of immune cells (plasma cells and lymphocytes) at the base of the glands, wedging between the glands and the muscle layer beneath them. This pattern of chronic-plus-active inflammation in the colon’s innermost lining is what distinguishes UC from a temporary infection or other causes of colitis.
Importantly, the inflammation in UC stays confined to this inner lining. It does not extend through the full thickness of the bowel wall. When deeper layers are involved, that raises concern for Crohn’s disease instead.
Distinguishing UC From Crohn’s Disease
About 5% to 15% of IBD cases are initially difficult to classify, so the distinction matters. The key differences come down to location, pattern, and depth.
- Location: UC affects only the colon and rectum. Crohn’s can strike anywhere from the mouth to the anus, though it most commonly involves the end of the small intestine and the colon.
- Pattern: UC spreads in a continuous line starting from the rectum. Crohn’s typically skips areas, leaving healthy stretches of bowel between inflamed segments.
- Depth: UC inflammation is limited to the innermost lining. Crohn’s can penetrate through all layers of the intestinal wall, which can lead to complications like fistulas and strictures that don’t occur in typical UC.
When the colonoscopy, biopsies, blood tests, and imaging still can’t distinguish between the two, the diagnosis is sometimes labeled “indeterminate colitis” until the disease declares itself more clearly over time.
How Disease Extent Is Classified
Once UC is confirmed, your doctor classifies how much of the colon is involved using a system called the Montreal Classification. This matters because extent influences treatment decisions and long-term monitoring.
- E1 (ulcerative proctitis): Inflammation is limited to the rectum only, not reaching past the junction where the rectum meets the sigmoid colon. This is the mildest extent and often responds to topical treatments.
- E2 (left-sided colitis): Inflammation extends from the rectum up to, but not beyond, the splenic flexure (roughly the left side of the colon).
- E3 (extensive colitis or pancolitis): Inflammation extends past the splenic flexure, potentially involving most or all of the colon. This carries the highest risk of complications and typically requires systemic treatment.
Disease extent can change over time. Someone initially diagnosed with E1 may progress to E2 or E3 in subsequent years, which is one reason follow-up colonoscopies are part of long-term UC management. The classification at any given point helps guide both the intensity of treatment and the frequency of cancer surveillance colonoscopies, since more extensive disease carries a higher long-term colorectal cancer risk.